India's Alivus Life Sciences gains on higher Q3 profit

Alivus Life Sciences

23/01/2025 09:27

** Shares of Alivus Life Sciences  ALIV.NS  rise 5.3% to
1,170 rupees
    ** Company, formerly called Glenmark Life Sciences, says Q3
profit up 15% at 1.37 bln rupees ($15.8 mln); revenue from
operations up 12% over the year earlier
    ** Results aided by strong demand in company's mainstay
active pharmaceutical ingredients segment
    ** Regions such as India, Europe, Japan and rest of the
world also contributed to growth, says company
    ** More than 177,000 shares change hands, 1.5 times their
30-day average
    ** Stock gained 50% in 2024


($1 = 86.4780 Indian rupees)

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))